February 9, 2012

Focus on Rheumatoid Arthritis

Bookmark and Share

Rheumatoid arthritis (RA) is a chronic inflammatory disease among the autoimmune disorders. It is a progressive disabling condition characterised by inflammation of the synovial tissue of the joints with an increase in the number of synovial cells (hyperplasia), infiltration by white blood cells and formation of new blood vessels. As a result, the synovium becomes [...]

Antidepressants – Update on suicidal thoughts and behaviour

Bookmark and Share

Further to previous articles regarding the risk of suicidal behaviours associated with use of antidepressants, most recently in relation to children and adolescents (Drug Safety Newsletter -Issue 21, 2006), a comprehensive review of available clinical trial data for individual antidepressants was undertaken at EU and US level to further assess the risk of suicidality in [...]

New data on Ebixa efficacy in moderate to severe AD

Bookmark and Share

New data analysis shows that memantine (Ebixa) is effective in treating and preventing specific behavioural symptoms associated with moderate to severe Alzheimer’s disease (AD), with benefits seen for agitation/aggression and delusions at week 12 and 24. Behavioural symptoms such as aggression, agitation and psychosis are common in the moderate to severe stages of the disease [...]

Leonore

Bookmark and Share

Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Levonorgestrel 100mcg, ethinylestradiol 20mcg. Description: White round biconvex coated tablet. Presentation: 3 x 21, €9.00 (1 month 21, €3.00). Indications: Oral contraception. Pharmacology: Ethinylestradiol is a potent oral synthetic oestrogen. Like natural estradiol, it has a proliferative action on epithelial tissues of female genital [...]

Toviaz

Bookmark and Share

Company: Pfizer Healthcare Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Fesoterodine 4mg, 8mg. Description: Light blue or blue, oval, biconvex, film-coated, prolonged-release tablets, engraved FS or FT on one side, respectively. Presentation: 4mg-28; 8mg-28. Indications: Symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome. [...]

Tredaptive

Bookmark and Share

Company: Merck Sharp & Dohme Ireland (Human Health) Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Nicotinic acid, 1000mg; laropiprant, 20mg. Description: Capsule shaped, white to off white modified-release tablets, with 552 debossed on one side. Presentation: 28, €16.79; 56, €33.59. Indications: Dyslipidaemia, particularly in patients with combined mixed dyslipidaemia (characterised by elevated levels [...]

Solpadeine capsules – New additional pack size available on GMS

Bookmark and Share

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd are pleased to announce that Solpadeine Capsules are now available in an additional pack size – 32s. This new pack size will be reimbursed under the GMS scheme from the 1st of September. Should you require any further information, please contact GlaxoSmithKline Consumer Healthcare (Ireland) Ltd. at (01) 4955572.

Discontinuations in the Canesten range

Bookmark and Share

Bayer HealthCare Consumer Care wishes to inform you that, due to internal range rationalisation, the following products have been discontinued: Canesten Solution 20ml, Canesten Dermalogical Powder, Canesten Internal Cream. Should you have any queries, please do not hesitate to contact Bayer Ltd, Ireland at (01) 2999313.

Discontinuation of Clonamp 500mg 500-pack

Bookmark and Share

Clonmel Healthcare Ltd wish to inform you that Clonamp 500mg 500 pack has been discontinued. Clonamp 250mg (100 pack) Clonamp 500mg (100 pack) Clonamp 125mg Suspension and Clonamp 250mg Suspension remain on the market. Should you have any queries, please do not hesitate to contact Clonmel Healthcare Ltd at (01) 620 4000.

Discontinuation of Prosobee

Bookmark and Share

Mead Johnson Nutritionals wish to inform you that the supply of Prosobee (Soya Infant Formula) will be discontinued in 2 months. This decision has been influenced by market trends and clinical recommendations. Mead Johnson Nutritionals no longer participate in this line of products. Should you require further information, please do not hesitate to contact Mead [...]

Next Page »